Nouvelles stratégies thérapeutiques dans les cancers du sein HER2-surexprimé: New therapeutic strategies in HER2-positive breast cancer.
Bull Cancer
; 108(11S): 11S8-11S18, 2021 Dec.
Article
in Fr
| MEDLINE
| ID: mdl-34969516
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Receptor, ErbB-2
/
Genes, erbB-2
/
Antineoplastic Agents, Immunological
Limits:
Female
/
Humans
Language:
Fr
Journal:
Bull Cancer
Year:
2021
Document type:
Article
Affiliation country:
Francia
Country of publication:
Francia